[The effect of sermion on brain function in diabetics].
The vasoactive drug sermion was used for the treatment of patients suffering of diabetes mellitus with clinical manifestations of central neuropathy. A course of sermion treatment effected positively the clinical course of neuropathy also confirmed electroencephalographically and by the parameters of visual and somatosensory evoked potentials of the brain. Results indicate the possibility of using sermion in the treatment of brain affections in patients with diabetes mellitus.
Efimov
A S
AS
Man'kovskiĭ
B N
BN
D000328:Adult; D000368:Aged; D001921:Brain / Q000187:drug effects* / Q000503:physiopathology; D002908:Chronic Disease; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D003929:Diabetic Neuropathies / Q000188:drug therapy* / Q000503:physiopathology; D004341:Drug Evaluation; D004569:Electroencephalography / Q000187:drug effects; D005073:Evoked Potentials, Somatosensory / Q000187:drug effects; D005074:Evoked Potentials, Visual / Q000187:drug effects; D006801:Humans; D008875:Middle Aged; D009530:Nicergoline / Q000627:therapeutic use*
D009530:Nicergoline
Vliianie sermiona na funktsional'noe sostoianie golovnogo mozga u bol'nykh sakharnym diabetom.